Facebook
X
LinkedIn
ForwardVOA DCN 2026
Utilizing the dynamic approach of interprofessional collaboration, Duke Cancer Network and Virginia Oncology Associates engage with renowned oncology providers to translate innovative advancements in diagnostics, technologies, and treatments into practice for primary brain tumors, multiple myeloma, breast cancer, lung cancer, melanoma and prostate cancer. With a focus on the intersectionality of cooperative oncology care, engaging sessions will also explore nursing implications in cancer care. The event will kick off with a thought-provoking discussion on the future of healthcare.
This course is open for anyone to attend, please use the link below to register for the course….
Target Audience
- Nurses
- Nurse Practitioners
- Physicians
- Physician Assistants
- Pharmacy Technicians
- Pharmacists
Learning Objectives
■ Examine emerging research in cancer prevention, management and survivorship.
■Distinguish collaborative care best practices in symptom management.
■ Elevate provider knowledge through discussion of evidence-based guidelines.
■ Increase knowledge on nursing implications in oncology care.
■ Educate about future of healthcare in the United States
Course summary
- 6.00 ACPE - Pharmacist
- 6.00 ACPE - Pharmacy Technician
- 6.00 AMA PRA Category 1 Credit(s)™
- 6.00 ANCC
- 6.00 Attendance
- 0.60 IACET CEU
- 6.00 JA Credit - AH
- Edward George, MD, FACP
- Elias Zerhouni, MD
- Shipra Gandhi, MD, MS
- Nikhil Khushalani, MD
- Misty Shield, MD, PhD
- Amanda Stewart, BSN, RN, CPN
- Katherine Peters, MD, PhD
- Corrie Camalier, PhD, FNP-C, CNS
- Vincent Rajkumar, MD
- Matthew Smith, MD, PhD
- ACPE - Pharmacy Technician
- ACPE - Pharmacist
- AMA PRA Category 1 Credit(s)
- ANCC
- Attendance
- IACET CEU
- JA Credit - AH
Available Credit
- 6.00 ACPE - Pharmacist
- 6.00 ACPE - Pharmacy Technician
- 6.00 AMA PRA Category 1 Credit(s)™
- 6.00 ANCC
- 6.00 Attendance
- 0.60 IACET CEU
- 6.00 JA Credit - AH